Anthem Biosciences IPO Description – Anthem Biosciences is a leading innovation-driven and technology-focused Contract Research, Development, and Manufacturing Organization (CRDMO) based in India. With fully integrated capabilities across drug discovery, development, and commercial manufacturing for both New Chemical Entities (NCEs) and New Biological Entities (NBEs), the company serves a global clientele that includes emerging biotech firms and large pharmaceutical companies.
Anthem differentiates itself through cutting-edge modalities such as RNAi, ADCs, peptides, lipids, and oligonucleotides, and advanced technologies like biotransformation, flow chemistry, and solid-state peptide synthesis. It offers comprehensive CRDMO services and manufactures specialty fermentation-based ingredients like probiotics, enzymes, and biosimilars. The company has executed over 8,000 projects for more than 675 customers across 44 countries, including long-standing partnerships with major pharma companies.
Promoters of Anthem Biosciences – Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa, and Ishaan Bhardwaj
Anthem Biosciences IPO Details
| Anthem Biosciences IPO Dates | 8 – 10 July 2025 |
| Anthem Biosciences IPO Price | Coming soon |
| Fresh issue | NIL |
| Offer For Sale | INR 3,395 crore |
| Total IPO size | INR 3,395 crore |
| Minimum bid (lot size) | Coming soon |
| Face Value | INR 2 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Anthem Biosciences Financial Performance
| FY 2022 | FY 2023 | FY 2024 | H1 FY 2025 | |
| Revenue | 1,231.26 | 1,056.92 | 1,419.37 | 863.55 |
| Expenses | 734.10 | 698.50 | 1,005.75 | 593.34 |
| Net income | 405.54 | 385.19 | 367.31 | 244.31 |
| Margin (%) | 32.94 | 36.44 | 25.88 | 28.29 |
Anthem Biosciences Offer News
Anthem Biosciences Valuations & Margins
| FY 2022 | FY 2023 | FY 2024 (Pre Issue) | FY 2025 (Post-Issue)* | |
| EPS | 7.11 | 6.75 | 6.48 | 8.58 |
| PE Ratio | – | – | – | – |
| FY 2022 | FY 2023 | FY 2024 | |
| RONW (%) | 39.48 | 24.93 | 20.03 |
| NAV | 1,543.94 | 30.51 | 34.43 |
| ROCE (%) | 41.01 | 28.94 | 25.22 |
| EBITDA (%) | 46.85 | 41.53 | 36.25 |
| Debt/Equity | 0.03 | 0.07 | 0.12 |
Anthem Biosciences IPO GMP Today (Daily Trend)
Anthem Biosciences IPO Subscription – Live Updates
Coming soon
NA Shares allotted to anchor investors are not included in these calculations. Similarly, NA shares allotted to market makers, if any, are not part of these calculations.
Anthem Biosciences – Comparison With Listed Peers
Anthem Biosciences IPO Allotment Status
Anthem Biosciences IPO allotment status will be available on the KFin Tech website. Click on this link to get allotment status.
Anthem Biosciences IPO Dates & Listing Performance
| IPO Opening Date | 8 July 2025 |
| IPO Closing Date | 10 July 2025 |
| Finalization of Basis of Allotment | 11 July 2025 |
| Initiation of refunds | 14 July 2025 |
| Transfer of shares to demat accounts | 14 July 2025 |
| Anthem Biosciences IPO Listing Date | 15 July 2025 |
| Opening Price on NSE | Coming soon |
| Closing Price on NSE | Coming soon |
Anthem Biosciences IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Antique Stock Broking –
Ajcon Global –
Arihant Capital –
Axis Capital –
Ashika Research –
BP Wealth –
Capital Market –
Canara Bank Securities –
Choice Broking –
Dalal & Broacha –
Elara Capital –
Elite Wealth –
GCL Broking –
Geojit –
GEPL Capital –
Hem Securities –
Hensex Securities –
HDFC Securities –
ICICIdirect –
IDBI Capital –
Investmentz –
Indsec Securities –
Jainam Broking –
KR Choksey –
LKP Research –
Marwadi Financial –
Motilal Oswal –
Mehta Equities –
Nirmal Bang –
Reliance Securities –
Sushil Finance –
Samco Securities –
SBI Securities –
SMC Global –
SMIFS –
Systematix Research –
Swastika Investmart –
Ventura Securities –
Anthem Biosciences Offer Lead Manager
JM FINANCIAL LIMITED
7th Floor, Cnergy, Appasaheb Marathe Marg,
Prabhadevi, Mumbai 400 025,
Maharashtra, India
Phone: +91 22 6630 3030
Email: [email protected]
Website: www.jmfl.com
Anthem Biosciences Offer Registrar
KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
ANTHEM BIOSCIENCES LIMITED
No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area,
Phase 1, Bommasandra, Bangalore, Karnataka, India, 560 099
Phone: +91 080 6672 4000
Email: [email protected]
Website: www.anthembio.com
Anthem Biosciences IPO FAQs
How many shares in the Anthem Biosciences IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for the Anthem Biosciences Public Offer?
The best way to apply for the Anthem Biosciences public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stockbroker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Anthem Biosciences IPO GMP today?
Anthem Biosciences IPO GMP today is INR NA per share.
What is Anthem Biosciences kostak rate today?
Anthem Biosciences’ kostak rate today is INR NA per application.
What is Anthem Biosciences Subject to Sauda rate today?
Anthem Biosciences Subject to Sauda rate today is INR NA per application.
